Inhibikase Back In Game As FDA Lifts Hold On Multiple System Atrophy Drug

 
• By Alaric DeArment
  
The FDA lifted a full clinical hold on Inhibikase's MSA program • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D